FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/07/015075 [Registered on: 26/07/2018] Trial Registered Retrospectively
Last Modified On: 21/09/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Therapeutic]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare the effect of Phalatrikadi Kwath and Vrinda Triphaladi Kwath in obesity 
Scientific Title of Study   A comparative study to evaluate the efficacy of Phalatrikadi Kwatha and Vrinda-Triphaladi Kwatha in Sthaulya (Obesity). 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Dr N R Singh 
Designation  Pofessor and HOD 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073

New Delhi
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr N R Singh 
Designation  Pofessor and HOD 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073

New Delhi
DELHI
110073
India 
Phone  9560659728  
Fax    
Email  naimishraj@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Parul Singh 
Designation  P G Scholar 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar Najafgarh New Delhi 110073

New Delhi
DELHI
110073
India 
Phone  920543184  
Fax    
Email  drparulbhadula@gmail.com  
 
Source of Monetary or Material Support  
Department of Kayachikitsa Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar New Delhi 110073  
 
Primary Sponsor  
Name  Chaudhary Brahm Prakash Ayurved Charak Sansthan 
Address  Khera Dabar Najafgarh New Delhi 110073 
Type of Sponsor  Other [Autonomous Ayurvedic Medical college and Hospital under Govt of NCT of Delhi] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Dr N R Singh  Chaudhary Brahm Prakash Ayurved Charak Sansthan Khera Dabar New Delhi  Room no 146 Deptt of Kayachikitsa
New Delhi
DELHI 
9560659728

naimishraj@yahoo.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee CBPACS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E669||Obesity, unspecified, (2) ICD-10 Condition: E669||Obesity, unspecified, Patients of either sex between 21 to 51 yr with BMI ranging from 25.0 to 35 Kg/m2,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Phalatrikadi Kwatha  20 patients will be given Phalatrikadi kwatha in dose of 40 ml after mixing 12 gm of haridra kalka and 12 ml of honey in it twice in a day (empty stomach in morning and four hour after lunch) for 21 days 
Comparator Agent  Vrinda triphaladi Kwatha  20 patients will be given Vrinda-Triphaladi kwatha in dose of 40 ml after mixing 12 gm of haridra kalka and 12 ml of honey in it twice in a day (empty stomach in morning and four hour after lunch) for 21 days 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  BMI ranging from 25.0 to 35 Kg/m2
Patients willing to participate and provide signed informed consent
 
 
ExclusionCriteria 
Details  Patients with Hypothyroidism
Patients suffering from drug induced Obesity
Patients with Diabetes
Patients with severe Hypertension
Patients with Renal Hepatic and Cardiac involvement
Pregnant and Lactating women
Patients having Gastro intestinal discomfort
Patients who are not willing to participate with the study
9.Any other condition which may jeopardize the study.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in Weight
Reduction in BMI
Reduction in Waist circumference
Reduction in Hip circumference
Reduction in Waist – Hip Ratio
Reduction in Serum VLDL
Reduction in Serum LDL
Reduction in Serum Triglycerides
Reduction in Serum Total Cholesterol and an increase in Serum HDL
Reduction in percentage relief in subjective criteria of Sthaulya 
Weight
BMI
Waist circumference
Hip circumference
Waist – Hip Ratio
subjective criteria of Sthaulya
on 0 day 21st day and 35th day
Serum VLDL
Serum LDL
Serum Triglycerides
Serum Total Cholesterol
Serum HDL
on 0 day and 21st day 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of reduction in the level of abdominal discomfort pain and Frequency of defecation during use of trial medicines  level of abdominal discomfort pain and Frequency of defecation
on 0 day 7th day 14th day and 21st day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   18/05/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary    

According to the inclusion and exclusion criteria patients will be randomly selected from OPD and IPD of Chaudhary Brahm Prakash Ayurved Charak Sansthan

Khera Dabar Najafgarh New Delhi

Informed written consent will be taken from all the subjects included in the study

Patients will be randomly divided into 2 groups of 20 patients each

In group A 20 patients will be given Phalatrikadi kwatha in dose of   40 ml after mixing 12 gm of haridra kalka and 12 ml of honey in it twice in a day empty stomach

in morning and four hour after lunch for 21 days

20 patients will be given Vrinda-Triphaladi kwatha in dose of 40 ml after mixing 12 gm of haridra kalka and 12 ml of honey in it twice in a day empty stomach in

morning and four hour after lunch for 21 days

A proforma will be prepared for diagnosis of disease and assessment of subjects

BMI Weight Waist circumference Hip Circumference Waist hip Ratio Subjective symptoms and Objective symptoms will be assessed before and after treatment and

during follow up

Lipid profile will be done before and after treatment

 Assessment of abdominal discomfort and abdominal pain and will also be done 0 day 7th day 14th day and 21st day

All the patients will be advised to follow the guidelines regarding pathya-apathya as described in Classical Ayurvedic texts during the trial period

Data will be statistically analyzed at the end of the study period

All the ethical issues will be maintained during the clinical trial

 
Close